Completely Disappear of Giant Lung Metastases of Pancreatic Cancer Treated with Gemcitabine and Oxaliplatin Chemotherapy: A Case ReportYu Yuan1 and Ren Cheng Sun2*
- *Corresponding Author:
- Ren Cheng Sun
Department of Surgical Oncology
Wei Fang Traditional Chinese Hospital
Shan Dong province, P.R China
E-mail: [email protected]
Received date: May 08, 2017; Accepted date: June 15, 2017; Published date: June 22, 2017
Citation: Yuan Y, Sun RC (2017) Completely Disappear of Giant Lung Metastases of Pancreatic Cancer Treated with Gemcitabine and Oxaliplatin Chemotherapy: A Case Report. J Clin Case Rep 7:984. doi: 10.4172/2165-7920.1000984
Copyright: © 2017 Yuan Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Pancreatic cancer is one of the most lethal cancers, most patients (80%) were diagnosed as inoperable advanced pancreatic cancer at the first time, and over 60% patients received operation relapsed within 2 years. Chemotherapy remains the mainly treatment for inoperable advanced or recurrent pancreatic cancer. Even though, gemcitabine and oxaliplatin was approved as a first-line therapy for advanced pancreatic cancer, their effect is unsatisfactory, especially for cases with distant metastases. In this paper, we report a case of lung metastases of pancreatic cancer showed complete response (CR) after received gemcitabine and oxaliplatin chemotherapy. This patient has a 9.5 cm × 9 cm × 7.5 cm size mass in right lung, three years after whipple procedure for pancreatic cancer. Then, the lung metastases disappeared completely, after 6 cycles of GEMOX. The result of this case report hints us GEMOX was a better choice for metastatic pancreatic cancer than other combination chemotherapy, especially for patients with distant metastasis to lung.